Changes in how brain cells generate energy may drive the development of Alzheimer’s disease and influence how patients respond to therapy, according to a new study from Mayo Clinic researchers. The findings, published in the journal Alzheimer’s & Dementia, spotlight mitochondrial complex I—a critical component of cellular energy production—as both a contributor to disease progression and a promising target for new treatments.
This article was originally published on MedicalXpress.com